{
    "clinical_study": {
        "@rank": "154624", 
        "acronym": "BOCLA-Mort", 
        "arm_group": [
            {
                "arm_group_label": "Standard therapy", 
                "description": "Antiplatelet therapy following coronary stenting without platelet function testing"
            }, 
            {
                "arm_group_label": "Optimized antiplatelet therapy", 
                "description": "Platelet function testing and according to a test and treat strategy improve the antiplatelet therapy in low-responder.\nTreatment adjustments were done as published before - see BOCLA-Plan manuscript. (Reference: Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011 Jan 12;9:3.)"
            }
        ], 
        "brief_summary": {
            "textblock": "Comparing standard treatment versus optimized antiplatelet therapy and outcomes measures."
        }, 
        "brief_title": "The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is aimed to evaluate if optimized antiplatelet treatment using a test and treat\n      algorithm (with whole blood aggregometry) is able to improve clinical outcome of patients\n      compared to standard treatment without platelet function testing."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  coronary stent implantation\n\n        Exclusion Criteria:\n\n          -  no consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients following coronary stenting if informed consent was obtained"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01796691", 
            "org_study_id": "BOCLAplan02", 
            "secondary_id": "[Ruhr-University Bochum]"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Aspirin", 
                "Clopidogrel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Clopidogrel", 
            "aspirin", 
            "low response", 
            "platelet aggregation", 
            "Acute Coronary Syndrome", 
            "Coronary Stent Implantation"
        ], 
        "lastchanged_date": "February 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bochum", 
                    "country": "Germany", 
                    "state": "NRW", 
                    "zip": "D-44791"
                }, 
                "name": "Cardiovascular Center, Ruhr-University Bochum"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.", 
        "overall_official": {
            "affiliation": "Ruhr-University Bochum, Cardiovascular Center", 
            "last_name": "Horst Neubauer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "MACE-rate", 
            "measure": "Adverse cardiac events (MACE: mortality,rehospitalisation,myocardial infarction)", 
            "safety_issue": "No", 
            "time_frame": "Follow up for up to 12 months (retrospective analysis)"
        }, 
        "reference": [
            {
                "PMID": "21226927", 
                "citation": "Neubauer H, Kaiser AF, Endres HG, Kr\u00fcger JC, Engelhardt A, Lask S, Pepinghege F, Kusber A, M\u00fcgge A. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011 Jan 12;9:3. doi: 10.1186/1741-7015-9-3."
            }, 
            {
                "PMID": "18278186", 
                "citation": "Neubauer H, Lask S, Engelhardt A, M\u00fcgge A. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification. Thromb Haemost. 2008 Feb;99(2):357-62."
            }, 
            {
                "PMID": "22656044", 
                "citation": "Siller-Matula JM, Francesconi M, Dechant C, Jilma B, Maurer G, Delle-Karth G, Gouya G, Ruzicka K, Podczeck-Schweighofer A, Christ G. Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study. Int J Cardiol. 2012 May 30. [Epub ahead of print]"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01796691"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ruhr University of Bochum", 
            "investigator_full_name": "Horst Neubauer", 
            "investigator_title": "PHD, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ruhr University of Bochum", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ruhr University of Bochum", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}